Breaking News Instant updates and real-time market news.

SLB

Schlumberger

$33.96 /

+0.01 (+0.03%)

04:55
01/29/20
01/29
04:55
01/29/20
04:55

Schlumberger management to meet with RBC Capital

Meeting to be held in Kansas City on January 29 hosted by RBC Capital.

  • 29

    Jan

  • 01

    Mar

SLB Schlumberger
$33.96 /

+0.01 (+0.03%)

01/21/20
Fly Intel: Top five analyst downgrades
01/21/20 Morgan Stanley
Schlumberger highlighted material tailwinds in 2020 outlook, says Morgan Stanley
01/21/20 Cowen
Schlumberger risk to estimates seen, Cowen downgrades to Market Perform
01/21/20 Cowen
Schlumberger downgraded to Market Perform from Outperform at Cowen

TODAY'S FREE FLY STORIES

Earnings
Evolus reports Q4 EPS (47c), consensus (73c) » 07:22
02/25/20
02/25
07:22
02/25/20
07:22
EOLS

Evolus

$9.35 /

-0.89 (-8.69%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Home Depot outlook affirmed with upside bias seen, says Baird » 07:21
02/25/20
02/25
07:21
02/25/20
07:21
HD

Home Depot

$239.77 /

-5.56 (-2.27%)

Baird analyst Peter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Palo Alto Networks price target lowered to $240 from $275 at Wedbush » 07:21
02/25/20
02/25
07:21
02/25/20
07:21
PANW

Palo Alto Networks

$236.99 /

-5.87 (-2.42%)

Wedbush analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Intuit price target raised to $320 from $303 at BofA » 07:20
02/25/20
02/25
07:20
02/25/20
07:20
INTU

Intuit

$286.50 /

-11.27 (-3.78%)

BofA analyst Kash Rangan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Montage Resources reports Q4 net production averaged 623.4 MMcfe per day » 07:19
02/25/20
02/25
07:19
02/25/20
07:19
MR

Montage Resources

$3.39 /

-0.255 (-7.00%)

Net production for the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Chimerix expects to submit BCV NDA for smallpox in mid-2020 » 07:19
02/25/20
02/25
07:19
02/25/20
07:19
CMRX

Chimerix

$1.75 /

+0.025 (+1.45%)

In January, Chimerix…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Dine Brands price target raised to $110 from $100 at Wedbush » 07:18
02/25/20
02/25
07:18
02/25/20
07:18
DIN

Dine Brands

$96.06 /

-1.13 (-1.16%)

Wedbush analyst Nick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Chimerix to initiate Phase 3 trial of DSTAT w/ chemotherapy mid-year » 07:18
02/25/20
02/25
07:18
02/25/20
07:18
CMRX

Chimerix

$1.75 /

+0.025 (+1.45%)

Chimerix recently…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
United Airlines' long-term opportunity remains, says BofA » 07:17
02/25/20
02/25
07:17
02/25/20
07:17
UAL

United Airlines

$75.46 /

-2.56 (-3.28%)

BofA analyst Andrew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Duke Realty management to meet with SunTrust » 07:17
02/25/20
02/25
07:17
02/25/20
07:17
DRE

Duke Realty

$37.71 /

-1.12 (-2.88%)

Dinner Meeting to be held…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Lantheus sees FY20 adj. EPS $1.34-$1.40, consensus $1.03 » 07:16
02/25/20
02/25
07:16
02/25/20
07:16
LNTH

Lantheus

$16.11 /

-0.46 (-2.78%)

Sees FY20 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Chimerix reports Q4 EPS (6c), two est. (17c) » 07:16
02/25/20
02/25
07:16
02/25/20
07:16
CMRX

Chimerix

$1.75 /

+0.025 (+1.45%)

Reports Q4 revenue $6.8M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Aeglea BioTherapeutics price target raised to $24 from $20 at H.C. Wainwright » 07:16
02/25/20
02/25
07:16
02/25/20
07:16
AGLE

Aeglea BioTherapeutics

$7.42 /

-0.42 (-5.36%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
United Therapeutics price target raised to $243 from $237 at Wedbush » 07:15
02/25/20
02/25
07:15
02/25/20
07:15
UTHR

United Therapeutics

$115.29 /

+8.33 (+7.79%)

Wedbush analyst Liana…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Nutrien announces TSX approval for renewed share repurchase program » 07:15
02/25/20
02/25
07:15
02/25/20
07:15
NTR

Nutrien

$42.02 /

-0.555 (-1.30%)

Nutrien announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Epizyme price target raised to $36 from $25 at H.C. Wainwright » 07:14
02/25/20
02/25
07:14
02/25/20
07:14
EPZM

Epizyme

$21.65 /

-3.24 (-13.02%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Lantheus sees Q1 adj. EPS 25c-27c, one estimate 3c » 07:14
02/25/20
02/25
07:14
02/25/20
07:14
LNTH

Lantheus

$16.11 /

-0.46 (-2.78%)

Sees Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Proteostasis announces publication of of nonclinical data on PTI-428 » 07:14
02/25/20
02/25
07:14
02/25/20
07:14
PTI

Proteostasis

$1.94 /

-0.05 (-2.51%)

Proteostasis Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
MediWound sees 2020 cash use $11M-$13M » 07:13
02/25/20
02/25
07:13
02/25/20
07:13
MDWD

MediWound

$2.93 /

-0.04 (-1.35%)

As of December 31, 2019,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
JPMorgan sees medium-term ROTCE target 17% » 07:13
02/25/20
02/25
07:13
02/25/20
07:13
JPM

JPMorgan

$132.16 /

-3.65 (-2.69%)

Sees medium-term overhead…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
JPMorgan sees NII falling to $57B in 2020 » 07:13
02/25/20
02/25
07:13
02/25/20
07:13
JPM

JPMorgan

$132.16 /

-3.65 (-2.69%)

Sees NII of $60B+/- in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Royal Caribbean removed from Best Ideas List at Wedbush » 07:12
02/25/20
02/25
07:12
02/25/20
07:12
RCL

Royal Caribbean

$96.53 /

-9.56 (-9.01%)

Wedbush is removing Royal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Lantheus reports Q4 adj. EPS 34c, consensus 30c » 07:12
02/25/20
02/25
07:12
02/25/20
07:12
LNTH

Lantheus

$16.11 /

-0.46 (-2.78%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
MediWound reports Q4 EPS (13c), consensus (10c) » 07:12
02/25/20
02/25
07:12
02/25/20
07:12
MDWD

MediWound

$2.93 /

-0.04 (-1.35%)

Reports Q4 revenue $5.4M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Carrols Restaurant sees total restaurant sales $1.64B-$1.69B, consensus $1.67B » 07:12
02/25/20
02/25
07:12
02/25/20
07:12
TAST

Carrols Restaurant

$5.13 /

+0.05 (+0.98%)

Comparable restaurant…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.